Literature DB >> 1577101

Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice.

C Mathis1, A Ungerer.   

Abstract

The dose-related time course and occurrence of different seizure subtypes was examined in mice after i.c.v. administration of N-methyl-D-aspartate (NMDA), kainate (KA) or quisqualate (QA). At doses of 0.2 to 1 nmol, NMDA dose-dependently induced a single clonic-tonic seizure. Low doses (0.1 to 0.3 nmol) of KA induced only mild myoclonus and whole body clonus, which were dose-dependently replaced by short-delay clonic-tonic seizures at higher doses (0.4 to 1.2 nmol). In contrast, mice treated with 13 to 32 nmol of QA exhibited either mild myoclonus or whole body clonus as well as clonic-tonic seizures. Clonic-tonic seizures induced by NMDA or KA appeared at shorter latencies than those induced by QA, whereas whole body clonus induced by KA or QA appeared with long onset latencies. These results clearly show that i.c.v. administration of NMDA, KA and QA produces different patterns of seizures in mice. This study confirms that NMDA, KA and QA induce convulsions through different underlying mechanisms and suggests that different anatomical pathways are involved in these models.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577101     DOI: 10.1007/bf02259102

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  32 in total

1.  Excitatory amino acids are elevated in human epileptic cerebral cortex.

Authors:  A Sherwin; Y Robitaille; F Quesney; A Olivier; J Villemure; R Leblanc; W Feindel; E Andermann; J Gotman; F Andermann
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

2.  Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants.

Authors:  J L Moreau; L Pieri; B Prud'hon
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

3.  Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra.

Authors:  G De Sarro; B S Meldrum; C Reavill
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

Review 4.  Minireview. Kainic acid as a tool for the study of temporal lobe epilepsy.

Authors:  J V Nadler
Journal:  Life Sci       Date:  1981-11-16       Impact factor: 5.037

5.  Kainic acid: a powerful neurotoxic analogue of glutamate.

Authors:  J W Olney; V Rhee; O L Ho
Journal:  Brain Res       Date:  1974-09-13       Impact factor: 3.252

6.  Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects.

Authors:  W Koek; F C Colpaert
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

Review 7.  Progression and generalization of seizure discharge: anatomical and neurochemical substrates.

Authors:  K Gale
Journal:  Epilepsia       Date:  1988       Impact factor: 5.864

8.  Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?

Authors:  L Turski; B S Meldrum; J F Collins
Journal:  Brain Res       Date:  1985-06-10       Impact factor: 3.252

9.  Seizure susceptibility in DBA and C57 mice: the effects of various convulsants.

Authors:  F L Engstrom; D M Woodbury
Journal:  Epilepsia       Date:  1988 Jul-Aug       Impact factor: 5.864

10.  CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.

Authors:  J Lehmann; A J Hutchison; S E McPherson; C Mondadori; M Schmutz; C M Sinton; C Tsai; D E Murphy; D J Steel; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

View more
  5 in total

1.  NR1 knockdown reveals CA1 injury during a developmental period of high seizure susceptibility despite reduced seizure activity.

Authors:  J Kaur; R Keesey; B Magrys; H Liu; L K Friedman
Journal:  Neuromolecular Med       Date:  2007-08-14       Impact factor: 3.843

2.  Analysis of flurothyl-induced myoclonus in inbred strains of mice.

Authors:  Dominick Papandrea; Whitney S Kukol; Tara M Anderson; Bruce J Herron; Russell J Ferland
Journal:  Epilepsy Res       Date:  2009-09-09       Impact factor: 3.045

3.  Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Javier Garzón
Journal:  Oncotarget       Date:  2018-05-04

4.  Trophic factors intervention regenerates the nestin-expressing cell population in a model of perinatal excitotoxicity: Implications for perinatal brain injury and prematurity.

Authors:  A Espinosa-Jeffrey; R A Arrazola; B Chu; A Taniguchi; S M Barajas; P Bokhoor; J Garcia; A Feria-Velasco; J de Vellis
Journal:  Integr Mol Med       Date:  2016-06-25

5.  Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.

Authors:  María Rodríguez-Muñoz; Yara Onetti; Elsa Cortés-Montero; Javier Garzón; Pilar Sánchez-Blázquez
Journal:  Mol Brain       Date:  2018-09-17       Impact factor: 4.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.